How the TRPV3 skin sensor turns on and off
Structural and functional principles of activation and regulation of the transient receptor potential channel TRPV3.
Researchers are learning how the TRPV3 protein in skin cells responds to heat, chemicals, and genetic changes because that affects conditions like eczema, chronic itch, and some hair disorders.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Columbia University Health Sciences NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11258983 on NIH RePORTER |
What this research studies
This work focuses on TRPV3, a protein found mainly in skin cells that helps sense temperature, pain, and itch. The team will use biochemical and biophysical methods to see how small molecules, heat, and disease-causing mutations change TRPV3’s shape and activity. They aim to map how the channel is activated and how it can be blocked at the molecular level. Understanding these mechanisms could guide future treatments targeting TRPV3-related skin problems.
Who could benefit from this research
Good fit: People with chronic skin conditions linked to TRPV3 such as severe eczema/atopic dermatitis, chronic unexplained itch, Olmsted syndrome, certain forms of hair loss, rosacea, or acne might be the most relevant group for future therapies arising from this work.
Not a fit: Patients whose symptoms are driven by causes unrelated to TRPV3 or who need immediate clinical treatment are unlikely to benefit directly from this basic science project in the short term.
Why it matters
Potential benefit: If successful, this research could enable the design of drugs or molecules that correct or block faulty TRPV3 activity to relieve itch, inflammation, or related skin disorders.
How similar studies have performed: Previous laboratory and animal studies have linked TRPV3 to skin disease and a few experimental compounds can modulate the channel, but detailed structural insights remain limited and this project builds on emerging but incomplete evidence.
Where this research is happening
New York, United States
- Columbia University Health Sciences — New York, United States (Active)
Researchers
- Principal investigator: Sobolevsky, Alexander — Columbia University Health Sciences
- Study coordinator: Sobolevsky, Alexander
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.